Jazz Pharmaceuticals
Price & Volume
Stats
See more52W Range | $99.06-$134.17 |
Market Cap | $7.6B |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $3.9B |
Revenue Growth (YoY) | 8.5% |
Gross Profit (12 Mos) | $3.3B |
Diluted EPS | $7.06 |
News
See moreYahoo Finance • 2 months ago
Jazz Pharmaceuticals' Zepzelca/Tecentriq Combo Regimen Can Potentially Delay Disease Progression, Extend Survival In Aggressive Form Of Lung Cancer
Yahoo Finance • 3 months ago
Is Jazz Pharmaceuticals plc (NASDAQ:JAZZ) The Top Stock With Improving Technical Ratings According To Piper Sandler?
Yahoo Finance • 3 months ago
Jazz Pharmaceuticals plc (JAZZ): Why Are Hedge Funds Bullish On This Cheap Growth Stock Right Now?
Yahoo Finance • 3 months ago
Jazz Pharmaceuticals' (NASDAQ:JAZZ) earnings have declined over five years, contributing to shareholders 16% loss
About
CEO | Mr. Bruce C. Cozadd |
CFO | Mr. Philip L. Johnson |
Address | Waterloo Exchange, Dublin, Ireland, D04 E5W7 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 2,800 |
